Water-soluble polymers coupled with glycopeptide antigens and T-cell epitopes as potential antitumor vaccines.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Angewandte Chemie

• Publication date

  2013-09-27

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1002/anie.201304212PMID 24038824
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Vaccine delivery using nanoparticles

  2013cited by this paper
• MUC1‐Glycopeptidkonjugate mit T‐Zellepitopen von Tetanus‐Toxoid als vollsynthetische Antitumor‐Vakzine mit Eigenverstärkungseffekt

  2013cited by this paper
• Self-adjuvanting synthetic antitumor vaccines from MUC1 glycopeptides conjugated to T-cell epitopes from tetanus toxoid.

  2013cited by this paper
• The development of synthetic antitumour vaccines from mucin glycopeptide antigens.

  2013cited by this paper
• Fully synthetic self-adjuvanting thioether-conjugated glycopeptide-lipopeptide antitumor vaccines for the induction of complement-dependent cytotoxicity against tumor cells.

  2013cited by this paper
• Micro and Nanoparticle‐Based Delivery Systems for Vaccine Immunotherapy: An Immunological and Materials Perspective

  2013cited by this paper
• Synthesis and immunological evaluation of self-assembling and self-adjuvanting tricomponent glycopeptide cancer-vaccine candidates.

  2012cited by this paper
• Aggregation behavior of amphiphilic p(HPMA)-co-p(LMA) copolymers studied by FCS and EPR spectroscopy.

  2012cited by this paper
• Linear-Hyperbranched Graft-Copolymers via Grafting-to Strategy Based on Hyperbranched Dendron Analogues and Reactive Ester Polymers

  2012cited by this paper
• Self-adjuvanting multicomponent cancer vaccine candidates combining per-glycosylated MUC1 glycopeptides and the Toll-like receptor 2 agonist Pam3CysSer.

  2011cited by this paper
• Nanoparticle Delivery Systems in Cancer Vaccines

  2011cited by this paper
• Modifying the body distribution of HPMA-based copolymers by molecular weight and aggregate formation.

  2011cited by this paper
• Engineering O-glycosylation points in non-extended peptides: implications for the molecular recognition of short tumor-associated glycopeptides.

  2011cited by this paper
• Immune recognition of tumor-associated mucin MUC1 is achieved by a fully synthetic aberrantly glycosylated MUC1 tripartite vaccine

  2011cited by this paper
• Synthetic antitumor vaccines containing MUC1 glycopeptides with two immunodominant domains-induction of a strong immune response against breast tumor tissues.

  2011cited by this paper
• Synthetische Antitumor‐Vakzine aus MUC1‐Glycopeptiden mit zwei immundominanten Domänen – Induktion einer starken Immunreaktion gegen Brusttumorgewebe

  2011cited by this paper
• Synthetic antitumor vaccines from tetanus toxoid conjugates of MUC1 glycopeptides with the Thomsen-Friedenreich antigen and a fluorine-substituted analogue.

  2010cited by this paper
• Immunogenicity and immunomodulatory properties of HPMA-based polymers.

  2010cited by this paper
• A high-throughput O-glycopeptide discovery platform for seromic profiling.

  2010cited by this paper
• Synthesis of MUC1-lipopeptide chimeras.

  2010cited by this paper
• Strategies in the design of nanoparticles for therapeutic applications

  2010cited by this paper
• Synthetische Antitumorvakzine aus Tetanus‐Toxoid‐Konjugaten von MUC1‐Glycopeptiden mit Thomsen‐Friedenreich‐Antigen und dessen fluorsubstituiertem Analogon

  2010cited by this paper
• MUC1 immunotherapy.

  2010cited by this paper
• Ein synthetischer Impfstoff aus einem tumorassoziierten Sialyl‐TN‐MUC1‐Tandem‐Repeat‐Glycopeptid und Tetanustoxoid zur Induktion einer starken, hochselektiven Immunantwort

  2009cited by this paper
• The uptake of N-(2-hydroxypropyl)-methacrylamide based homo, random and block copolymers by human multi-drug resistant breast adenocarcinoma cells.

  2009cited by this paper
• Identification of O-glycosylated decapeptides within the MUC1 repeat domain as potential MHC class I (A2) binding epitopes.

  2009cited by this paper
• Nanomedicine--challenge and perspectives.

  2009cited by this paper
• Radioactive labeling of defined HPMA-based polymeric structures using [18F]FETos for in vivo imaging by positron emission tomography.

  2009cited by this paper
• Tumor-associated MUC1 tandem-repeat glycopeptide microarrays to evaluate serum- and monoclonal-antibody specificity.

  2009cited by this paper
• The nature and sequence of the amino acid aglycone strongly modulates the conformation and dynamics effects of Tn antigen's clusters.

  2009cited by this paper
• Nanomedizin – Herausforderung und Perspektiven

  2009cited by this paper
• A synthetic vaccine consisting of a tumor-associated sialyl-T(N)-MUC1 tandem-repeat glycopeptide and tetanus toxoid: induction of a strong and highly selective immune response.

  2009cited by this paper
• Retargeting of Human T Cells to Tumor-Associated MUC1: The Evolution of a Chimeric Antigen Receptor1

  2008cited by this paper
• From defined reactive diblock copolymers to functional HPMA-based self-assembled nanoaggregates.

  2008cited by this paper
• Nanotechnology in vaccine delivery☆

  2008cited by this paper
• Identification of a novel cancer-specific immunodominant glycopeptide epitope in the MUC1 tandem repeat.

  2007cited by this paper
• Chemoenzymatically synthesized multimeric Tn/STn MUC1 glycopeptides elicit cancer-specific anti-MUC1 antibody responses and override tolerance.

  2006cited by this paper
• Cancer nanotechnology: opportunities and challenges

  2005cited by this paper
• A fully synthetic vaccine consisting of a tumor-associated glycopeptide antigen and a T-cell epitope for the induction of a highly specific humoral immune response.

  2005cited by this paper
• Eine vollsynthetische Vakzine aus einem tumorassoziierten Glycopeptid‐Antigen und einem T‐Zell‐Epitop zur Induktion einer hochspezifischen humoralen Immunantwort

  2005cited by this paper
• Structures of acidic O-linked polylactosaminoglycans on human skim milk mucins

  2005cited by this paper
• Cancer Immunotherapy: A Treatment for the Masses

  2004cited by this paper
• The dawning era of polymer therapeutics

  2003cited by this paper
• MUC1-like tandem repeat proteins are broadly immunogenic in cancer patients.

  2003cited by this paper
• Peptidotriazoles on solid phase: [1,2,3]-triazoles by regiospecific copper(i)-catalyzed 1,3-dipolar cycloadditions of terminal alkynes to azides.

  2002cited by this paper
• Hepatic drug targeting: phase I evaluation of polymer-bound doxorubicin.

  2002cited by this paper
• A stepwise huisgen cycloaddition process: copper(I)-catalyzed regioselective "ligation" of azides and terminal alkynes.

  2002cited by this paper
• Recombinant MUC1 Probe Authentically Reflects Cell-specific O-Glycosylation Profiles of Endogenous Breast Cancer Mucin

  2002cited by this paper
• Zur Entwicklung von Antitumor‐Impfstoffen: ein synthetisches Konjugat aus tumorassoziiertem MUC1‐Glycopeptidantigen und dem Tetanustoxin‐Epitop

  2001cited by this paper
• Towards the Development of Antitumor Vaccines: A Synthetic Conjugate of a Tumor-Associated MUC1 Glycopeptide Antigen and a Tetanus Toxin Epitope.

  2001cited by this paper
• Effects of glycosylation on fragments of tumour associated human epithelial mucin MUC1.

  1998cited by this paper
• Evaluation of N-(2-hydroxypropyl)methacrylamide copolymer-peptide conjugates as potential oral vaccines. Studies on their degradation by isolated rat small intestinal peptidases and their uptake by adult rat small intestinal tissue in vitro

  1996cited by this paper
• Monoclonal antibody BW835 defines a site-specific Thomsen-Friedenreich disaccharide linked to threonine within the VTSA motif of MUC1 tandem repeats.

  1995cited by this paper
• Biophysical characterization of one-, two-, and three-tandem repeats of human mucin (muc-1) protein core.

  1993cited by this paper
• Structural and computational investigations of the conformation of antigenic peptide fragments of human polymorphic epithelial mucin.

  1992cited by this paper
• Preclinical evaluation of polymer-bound doxorubicin

  1992cited by this paper
• Use of human universally antigenic tetanus toxin T cell epitopes as carriers for human vaccination.

  1992cited by this paper
• A short sequence, within the amino acid tandem repeat of a cancer‐associated mucin, contains immunodominant epitopes

  1989cited by this paper
• Universally immunogenic T cell epitopes: promiscuous binding to human MHC class II and promiscuous recognition by T cells

  1989cited by this paper
• Biocompatibility of N-(2-hydroxypropyl) methacrylamide copolymers containing adriamycin. Immunogenicity, and effect on haematopoietic stem cells in bone marrow in vivo and mouse splenocytes and human peripheral blood lymphocytes in vitro.

  1989cited by this paper
• A highly immunogenic region of a human polymorphic epithelial mucin expressed by carcinomas is made up of tandem repeats.

  1988cited by this paper
• Immunogenicity of N‐(2‐hydroxypropyl) methacrylamide copolymers

  1985cited by this paper
• Polymeric Antitumor Agents on a Molecular and on a Cellular Level

  1981cited by this paper
• Differentiation antigens expressed by epithelial cells in the lactating breast are also detectable in breast cancers

  1981cited by this paper
• Polymere Antitumormittel auf molekularer und zellulärer Basis

  1981cited by this paper
• A human cell line from a pleural effusion derived from a breast carcinoma.

  1973cited by this paper

• A Glycopeptide Mosaic Vaccine Elicits Robust Antitumor Immunity by Targeting Glycan Heterogeneity

  2026cites this paper
• A "sweeter" approach to cancer immunotherapy: Glycopolymers as diverse tools for immune modulation.

  2025cites this paper
• Chemical Synthesis of Globo H and Mannobiose Glycopolymers and their Immunological Stimulation

  2024cites this paper
• Synthetic self‐adjuvanted multivalent Mucin 1 (MUC1) glycopeptide vaccines with improved in vivo antitumor efficacy

  2024cites this paper
• Amino-Acid-Derived Anionic Polyacrylamides with Tailored Hydrophobicity–Physicochemical Properties and Cellular Interactions

  2024cites this paper
• The bright side of chemistry: Exploring synthetic peptide‐based anticancer vaccines

  2024cites this paper
• Efficient Production of Self-Assembled Bioconjugate Nanovaccines against Klebsiella pneumoniae O2 Serotype in Engineered Escherichia coli

  2024cites this paper
• Glycoconjugate Vaccines: Platforms and Adjuvants for Directed Immunity.

  2024cites this paper
• Immunomodulatory glycomedicine: Introducing next generation cancer glycovaccines.

  2023cites this paper
• Strategies for Synthesizing and Enhancing the Immune Response of Cancer Vaccines Based on MUC1 Glycopeptide Antigens

  2023cites this paper
• Peptide-Decorated Degradable Polycarbonate Nanogels for Eliciting Antigen-Specific Immune Responses

  2023cites this paper
• Self-Reporting Activated Ester-Amine Reaction for Enantioselective Multi-Channel Visual Detection of Chiral Amines.

  2022cites this paper
• From Self-Organization to Tumor-Immune Therapy: How Things Started and How They Evolved.

  2022cites this paper
• Copolymers Derived from Two Active Esters: Synthesis, Characterization, Thermal Properties, and Reactivity in Post-Modification

  2022cites this paper
• Biomedical polymers: synthesis, properties, and applications

  2022cites this paper
• A Peptide Epitope−Synthetic Polymer Conjugate that Mimics Insecticidal Protein Receptors. Application in Environmental and Biological Analysis

  2022cites this paper
• Synthetic linear glycopolymers and their biological applications

  2021cites this paper
• A Strategy Based on Loop Analysis to Develop Peptide Epitopes: Application to SARS-CoV-2 Spike Protein

  2021cites this paper
• Design of Polymeric Carriers for Intracellular Peptide Delivery in Oncology Applications.

  2021cites this paper
• Well‐Defined Mannosylated Polymer for Peptide Vaccine Delivery with Enhanced Antitumor Immunity

  2021cites this paper
• Carbohydrate-Based Macromolecular Biomaterials.

  2021cites this paper
• Enhancing the immune response and tumor suppression effect of antitumor vaccines adjuvanted with non-nucleotide small molecule STING agonist

  2021cites this paper
• Surface Ligand Density Switches Glycovesicles between Monomeric and Multimeric Lectin Recognition

  2020cites this paper
• Chemical Strategies to Boost Cancer Vaccines.

  2020cites this paper
• Synthesis of Brush-Like Glycopolymers with Monodisperse, Sequence-Defined Side Chains and Their Interactions with Plant and Animal Lectins.

  2019cites this paper
• From LC‐polymers to Nanomedicines: Different Aspects of Polymer Science from a Materials Viewpoint

  2019cites this paper
• Improving Cancer Vaccine Efficiency by Nanomedicine

  2019cites this paper
• Modular Polymer Antigens to Optimize Immunity.

  2019cites this paper
• Design and synthesis of trivalent Tn glycoconjugate polymers by nitroxide-mediated polymerization

  2019cites this paper
• Design of a MUC1-based tricomponent vaccine adjuvanted with FSL-1 for cancer immunotherapy.

  2019cites this paper
• The effect of the branched chain polypeptide carrier on biodistribution of covalently attached B-cell epitope peptide (APDTRPAPG) derived from mucin 1 glycoprotein.

  2019cites this paper
• Biocompatible single-chain polymer nanoparticles loaded with an antigen mimetic as potential anticancer vaccine.

  2018cites this paper
• Immunoengineering through cancer vaccines – A personalized and multi‐step vaccine approach towards precise cancer immunity

  2018cites this paper
• Epitopes of MUC1 Tandem Repeats in Cancer as Revealed by Antibody Crystallography: Toward Glycopeptide Signature-Guided Therapy

  2018cites this paper
• Polymeric Selectin Ligands Mimicking Complex Carbohydrates: From Selectin Binders to Modifiers of Macrophage Migration.

  2017cites this paper
• Protein glycosylation in gastric and colorectal cancers: Toward cancer detection and targeted therapeutics.

  2017cites this paper
• Design of Novel Antigen-Specific Immunotherapies for the Treatment of Autoimmune Disorders

  2017cites this paper
• Polymere Selectinliganden als komplexe Glykomimetika: von Selectinbindung bis zur Modifizierung der Makrophagenmigration

  2017cites this paper
• Cationic Nanohydrogel Particles for Therapeutic Oligonucleotide Delivery.

  2017cites this paper
• Interleukin-13 peptide vaccine induces protective humoral immunity in murine asthma models

  2017cites this paper
• Practical Considerations, Challenges, and Limitations of Bioconjugation via Azide-Alkyne Cycloaddition.

  2017cites this paper
• Peptide‐Enhanced Selective Surface Deposition of Polymer‐Based Fragrance Delivery Systems

  2017cites this paper
• Size Tunable Core Crosslinked Micelles from HPMA‐Based Amphiphilic Block Copolymers

  2017cites this paper
• Synthesis of an MUC1 Glycopeptide Dendrimer Based on β-Cyclodextrin by Click Chemistry

  2017cites this paper
• 2.4 Self-Assembling Biomaterials☆

  2017cites this paper
• Self‐Assembled Nano‐Immunostimulant for Synergistic Immune Activation

  2017cites this paper
• Potentiating the immune response of MUC1-based antitumor vaccines using a peptide-based nanovector as a promising vaccine adjuvant.

  2017cites this paper
• Functional polymer materials affecting cell attachment.

  2017cites this paper
• Chemical Synthesis of GM2 Glycans, Bioconjugation with Bacteriophage Qβ, and the Induction of Anticancer Antibodies

  2016cites this paper
• Synthesis of cyclic peptide disulfide–PHPMA conjugates via sequential active ester aminolysis and CuAAC coupling

  2016cites this paper
• Valency and density matter: Deciphering impacts of immunogen structures on immune responses against a tumor associated carbohydrate antigen using synthetic glycopolymers.

  2016cites this paper
• Fully synthetic self-adjuvanting MUC1-fibroblast stimulating lipopeptide 1 conjugates as potential cancer vaccines.

  2016cites this paper
• Glycomaterials for immunomodulation, immunotherapy, and infection prophylaxis.

  2016cites this paper
• Probing the self-assembly and stability of oligohistidine based rod-like micelles by aggregation induced luminescence.

  2016cites this paper
• Targeting cells of the immune system: mannosylated HPMA-LMA block-copolymer micelles for targeting of dendritic cells.

  2016cites this paper
• Bioreducible Poly-L-Lysine-Poly[HPMA] Block Copolymers Obtained by RAFT-Polymerization as Efficient Polyplex-Transfection Reagents.

  2016cites this paper
• Immunological Evaluation of Recent MUC1 Glycopeptide Cancer Vaccines

  2016cites this paper
• Activated Ester Containing Polymers: Opportunities and Challenges for the Design of Functional Macromolecules.

  2016cites this paper
• Progress in Vaccine Development

  2015cites this paper
• Preparation of dual stimuli-responsive block copolymers based on different activated esters with distinct reactivities

  2015cites this paper
• Smart shape-controlled synthesis of poly(N-isopropylacrylamide)/chitosan/Fe3O4 microgels

  2015cites this paper
• Not just for tumor targeting: unmet medical needs and opportunities for nanomedicine.

  2015cites this paper
• CpG‐Loaded Multifunctional Cationic Nanohydrogel Particles as Self‐Adjuvanting Glycopeptide Antitumor Vaccines

  2015cites this paper
• Glycopeptide Nanoconjugates Based on Multilayer Self-Assembly as an Antitumor Vaccine.

  2015cites this paper
• Core-shell polymer nanoparticles for prevention of GSH drug detoxification and cisplatin delivery to breast cancer cells.

  2015cites this paper
• Poly-L-Lysine-Poly[HPMA] Block Copolymers Obtained by RAFT Polymerization as Polyplex-Transfection Reagents with Minimal Toxicity.

  2015cites this paper
• Synthesis of tumor-associated MUC1-glycopeptides and their multivalent presentation by functionalized gold colloids.

  2015cites this paper
• Peptide-based synthetic vaccines

  2015cites this paper
• Enhanced immunogenicity of multivalent MUC1 glycopeptide antitumour vaccines based on hyperbranched polymers.

  2015cites this paper
• A fully synthetic glycopeptide antitumor vaccine based on multiple antigen presentation on a hyperbranched polymer.

  2014cites this paper
• New perspectives of HPMA-based copolymers derived by post-polymerization modification.

  2014cites this paper
• Recent advances in peptide-based subunit nanovaccines.

  2014cites this paper
• Toward anticancer immunotherapeutics: well-defined polymer-antibody conjugates for selective dendritic cell targeting.

  2014cites this paper
• Postpolymerization modification using less cytotoxic activated ester polymers for the synthesis of biological active polymers.

  2014cites this paper
• A fully synthetic four-component antitumor vaccine consisting of a mucin glycopeptide antigen combined with three different T-helper-cell epitopes.

  2014cites this paper
• Synthetic multivalent glycopeptide-lipopeptide antitumor vaccines: impact of the cluster effect on the killing of tumor cells.

  2014cites this paper
• Carbohydrate antigen delivery by water soluble copolymers as potential anti-cancer vaccines.

  2014cites this paper
• Biochemie und Molekularbiologie 2013

  2014cites this paper
• RAFT-polymerized poly(hexafluoroisopropyl methacrylate)s as precursors for functional water-soluble polymers

  2014cites this paper
• Sensitive fluorometric detection of alkaline phosphatase using a water-soluble conjugated polymer

  2014cites this paper
• Multivalente synthetische Glycopeptid‐Lipopeptid‐Antitumorvakzine: Auswirkung des Cluster‐Effekts auf das Abtöten von Tumorzellen

  2014cites this paper
• Eine vollsynthetische Vier-Komponenten-Antitumor-Vakzine mit einem MUC1-Glycopeptid und drei verschiedenen T-Helferzell- Epitopen†

  2014cites this paper
• Strategy for Designing a Synthetic Tumor Vaccine: Multi-Component, Multivalency and Antigen Modification

  2014cites this paper
• A Moment of Reflection: Sixty Years After the Nobel Prize for Hermann Staudinger

  2013cites this paper